Switch to:
Pfizer Inc  (NYSE:PFE) ROC %: 13.70% (As of Sep. 2017)

Return on capital measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Pfizer Inc's annualized return on capital (ROC) for the quarter that ended in Sep. 2017 was 13.70%.

As of today, Pfizer Inc's WACC % is 7.75%. Pfizer Inc's return on capital is 13.20% (calculated using TTM income statement data). Pfizer Inc generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Pfizer Inc Annual Data

 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 ROC % 13.47 13.17 13.16 13.21 14.43

Pfizer Inc Quarterly Data

 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 ROC % 13.37 10.42 15.11 13.98 13.70

Calculation

Pfizer Inc's annualized Return on Capital (ROC) for the fiscal year that ended in Dec. 2016 is calculated as:

 Return on Capital (ROC) (A: Dec. 2016 ) = NOPAT / Average Invested Capital = Operating Income*(1-Tax Rate) / ( (Invested Capital (A: Dec. 2015 ) + Invested Capital (A: Dec. 2016 )) /2) = 13730 * ( 1 - 13.45% ) / ( (80607 + 84076) /2) = 11883.315 / 82341.5 = 14.43 %

 Invested Capital (A: Dec. 2015 ) = Book Value of Debt + Book Value of Equity - Cash = Long-Term Debt & Capital Lease Obligation + Current Portion of Long-Term Debt + Minority Interest + Total Equity - Cash = 28740 + 10159 + 278 + 64720 - 23290 = 80607

 Invested Capital (A: Dec. 2016 ) = Book Value of Debt + Book Value of Equity - Cash = Long-Term Debt & Capital Lease Obligation + Current Portion of Long-Term Debt + Minority Interest + Total Equity - Cash = 31398 + 10688 + 296 + 59544 - 17850 = 84076

Pfizer Inc's annualized Return on Capital (ROC) for the quarter that ended in Sep. 2017 is calculated as:

 Return on Capital (ROC) (Q: Sep. 2017 ) = NOPAT / Average Invested Capital = Operating Income*(1-Tax Rate) / ( (Invested Capital (Q: Jun. 2017 ) + Invested Capital (Q: Sep. 2017 )) /2) = 15140 * ( 1 - 20.28% ) / ( (88066 + 88136) /2) = 12069.608 / 88101 = 13.70 %

where

 Invested Capital (Q: {Q2}) = Book Value of Debt + Book Value of Equity - Cash = Long-Term Debt & Capital Lease Obligation + Current Portion of Long-Term Debt + Minority Interest + Total Equity - Cash = 34191 + 9514 + 326 + 58368 - 14333 = 88066

 Invested Capital (Q: Sep. 2017 ) = Book Value of Debt + Book Value of Equity - Cash = Long-Term Debt & Capital Lease Obligation + Current Portion of Long-Term Debt + Minority Interest + Total Equity - Cash = 34503 + 9448 + 340 + 60770 - 16925 = 88136

Note: The Operating Income data used here is four times the quarterly (Sep. 2017) operating income data.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Explanation

Return on Capital measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income rather than net income in the numerator. The second is the tax adjustment to this operating income, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income is the current year's number.

Why is Return on Capital important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Pfizer Inc's WACC % is 7.75%. Pfizer Inc's return on capital is {stock_data.stock.roic}}% (calculated using TTM income statement data). Pfizer Inc generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.

Be Aware

Like ROE and ROA, ROC is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Related Terms

From GuruFocus

###### JulucaÂ® (dolutegravir and rilpivirine) approved in US as first 2-drug regimen, once-daily, single pill - a complete regimen for the maintenance treatment of virologically suppressed HIV-1 infection

By PRNewswire about PFE 2017-11-21 19:00:04

From the Internet

###### Next Billion Dollar Blockbuster Value Investors Look Omeros Corporation Part 1

- Seekingalpha 2017-11-22 09:19:37

###### Daily Pharma Scoop Teva Valuation Delmar Lead Candidate Galapagos Commences Trial

- Seekingalpha 2017-11-22 08:44:05

###### Trading Quality Stocks Short Term Rates Higher Update

- Seekingalpha 2017-11-22 07:44:46

###### The 30 Dow Jones Stocks

- Fool 2017-11-21 15:39:00

###### ViiV Healthcare says FDA has approved its two-drug HIV regimen, in first such instance

- MarketWatch 2017-11-21 14:25:00

###### Medtronic's Strong Q1 Helps Send Healthcare Stocks Higher

- theStreet 2017-11-21 13:33:00

###### New Div Block Quarterly Earnings Round Ii Part 2

- Seekingalpha 2017-11-21 10:07:03

###### Is Merck & Co. Inc. a Buy?

- Fool 2017-11-21 06:12:00

###### Pfizer Inc 2017 Q3 Results Earnings Call Slides

- Seekingalpha 2017-11-20 21:39:50

###### Roche Rocks Good News

- Seekingalpha 2017-11-20 15:46:32

###### Six promising stocks to buy when the biotech correction ends

- MarketWatch 2017-11-20 12:39:00

###### Pfizer Scores Sutent Win Bristol Myers Looks Steal Thunder

- Seekingalpha 2017-11-20 10:58:33

###### 3 Things Biotech Learn Today November 20 2017

- Seekingalpha 2017-11-20 09:23:05

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)